SEG (SEG) Stock Price & Analysis
SEG (SEG) rose 0.65% to USD 26.26 as of September 8, 2026 at 03:33 UTC, according to Nexqual real-time market data.
SEG last closed at USD 26.26; the session ranged USD 26.05–26.44 on volume of 43,273 shares. Market capitalization is —, with a 52-week range of USD 17.74–29.61 (NYQ). Source: Nexqual, September 8, 2026 at 03:33 UTC.
Key Statistics (as of September 8, 2026 at 03:33 UTC)
| Price | USD 26.26 |
|---|---|
| Change | ▲ 0.65% (up) |
| Previous Close | USD 26.26 |
| Open | USD 26.26 |
| Day Range | USD 26.05 – 26.44 |
| 52-Week Range | USD 17.74 – 29.61 |
| Volume | 43,273 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (SEG)
Nexqual's technical model rates SEG "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 03:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.39 (neutral) |
| vs SMA50 | Below (USD 26.76) |
| MACD | -0.16 (negative) |
From SEG's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QNTM | Quantum Biopharma Ltd. | USD 3.24 | ▲ 5.19% |
| SGI | Somnigroup International Inc. | USD 69.87 | ▲ 3.02% |
| STK | Columbia Seligman Premium Techn | USD 52.56 | ▲ 0.94% |
| COMS | COMSovereign Holding Corp. | USD 0 | ▲ 0% |
| ASND | Ascendis Pharma A/S | USD 270.56 | ▲ 1.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:33 UTC. This page is informational and not investment advice.